Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Richard Morrison

TitleExec Assoc Dean for Research
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentCollege of Medicine Administration
DivisionBasic Research
Address506B Biomedical Research I
200 South Cedar
Mail Slot # 791-1
Little Rock AR 72202
Phone501-686-8599
vCardDownload vCard

    Collapse Research Funds 
    Collapse principal investigator/co-principal investigator research activities
    R56AI099278     (MORRISON, RICHARD)May 1, 2017 - Apr 30, 2019
    NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: Indiana University
    Genetic analysis of mechanisms of chlamydial immune evasion
    Role: Principal Investigator

    P20GM103625     (SMELTZER, MARK S)Aug 15, 2012 - Apr 30, 2022
    NIH/NIGMS
    Center for Microbial Pathogenesis and Host Inflammatory Responses
    Role: Co-Investigator

    R01AI009278     (MORRISON, RICHARD)Feb 1, 2012 - Apr 30, 2017
    NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: Indiana University
    Genetic analysis of mechanisms of chlamydial immune evasion
    Role: Principal Investigator

    R01AI099278     (MORRISON, RICHARD)Feb 1, 2012 - Apr 30, 2017
    NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: Indiana University
    Genetic analysis of mechanisms of chlamydial immune evasion
    Role: Principal Investigator

    Research Agreement     (YACCOBY, SHMUEL)May 31, 2006 - May 31, 2009
    ZymoGenetics, Inc
    Effect of TACI-lg and BAFFR-lg on primary myeloma growth in SCID-hu mice
    Role: Principal Investigator

    R01AI038991     (MORRISON, RICHARD P.)Jun 1, 1996 - Aug 31, 2012
    NIH/NIAID
    Immunity to Chlamydial Genital Infection
    Role: Principal Investigator

    R56AI038991     (MORRISON, RICHARD P.)Jun 1, 1996 - Sep 14, 2006
    NIH/NIAID
    Immunity to Chlamydial Genital Infection
    Role: Principal Investigator

    T32AI007465     (MORRISON, RICHARD P.)Sep 30, 1994 - Aug 31, 2004
    NIH/NIAID
    MEDICAL MYCOLOGY PREDOCTORAL TRAINING PROGRAM
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Morrison SG, Giebel AM, Toh EC, Spencer HJ, Nelson DE, Morrison RP. Chlamydia muridarum Genital and Gastrointestinal Infection Tropism Is Mediated by Distinct Chromosomal Factors. Infect Immun. 2018 07; 86(7). PMID: 29661932.
      View in: PubMed
    2. Naglak EK, Morrison SG, Morrison RP. Neutrophils Are Central to Antibody-Mediated Protection against Genital Chlamydia. Infect Immun. 2017 10; 85(10). PMID: 28739831.
      View in: PubMed
    3. Naglak EK, Morrison SG, Morrison RP. IFN? is Required for Optimal Antibody-Mediated Immunity against Genital Chlamydia Infection. Infect Immun. 2016 11; 84(11):3232-3242. PMID: 27600502.
      View in: PubMed
    4. Morrison SG, Farris CM, Sturdevant GL, Whitmire WM, Morrison RP. Murine Chlamydia trachomatis genital infection is unaltered by depletion of CD4+ T cells and diminished adaptive immunity. J Infect Dis. 2011 Apr 15; 203(8):1120-8. PMID: 21321103.
      View in: PubMed
    5. Farris CM, Morrison RP. Vaccination against chlamydial genital infection utilizing the murine C. muridarum model. Infect Immun. 2011; (79):986-996.
    6. Farris CM, Morrison RP. Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model. Infect Immun. 2011 Mar; 79(3):986-96. PMID: 21078844.
      View in: PubMed
    7. Farris CM, Morrison SG, Morrison RP. CD4+ T Cells and antibody are required for optimal major outer membrane protein vaccine-unduced immunity to Chlamydia muridarum genital infection. Infect Immun. 2010; (78):4374-4383.
    8. Morrison SG, Morrison RP. Humoral immunity to Chlamydia muridarum genital tract reinfection. Chlamydial Infections: Proceedings of the Eleventh International Symposium on Human Chlamydial Infections. 2006; 373-376.
    9. Tiitinen A, Surcel H-M, Halttunen M, Birkelund S, Bloigu A, Christiansen G, Koskela P, Morrison SG, Morrison RP, Paavonen J. Chlamydia trachomatis and chlamydial heat shock protein 60-specific antibody and cell-mediated responses predict tubal factor infertility. Hum. Reprod. 2006; 21:1533-1538.
    10. Morrison SG, Morrison RP. A predominant role for antibody in acquired immunity to chalmydial genital tract reinfection. J Immunol. 2005; 175:7536-7542.
    11. Morrison SG, Morrison RP. The protective effect of antibody in immunity to murine chlamydial genital tract reinfection in dependent of IgA. Infect Immun. 2005; 73:6183-6186.
    12. RUSSELL MW, SPARLING PF, Morrison RP, CAUCI S, FIDEL, JR PL, MARTIN D, HOOK III EW, MESTECKY J. MUCOSAL IMMUNOLOGY OF SEXUALLY TRANSMITTED DISEASES. MUCOSAL IMMUNOLOGY. 2005; PP 1693-1720.
    13. Morrison RP. CHLAMYDIAL IMMUNOLOGY AND VACCINOLOGY. PROCEEDINGS OF THE CHLAMYDIAL VACCINE DEVELOPMENT COLLOQUIUM. 2003; PP 19-22.
    14. Jacobs JM, Bailey BW, Burritt JB, Morrison SG, Morrison RP, Dratz EA, Jesaitis AJ, Teintze M. QSYP peptide sequence is selected from phage display libraries by povine IgG contaminants in monoclonal antibody preparations. Biotecniques. 2003; 34:132-141.
    15. Perschinka H, Mayr M, Millonig G, Mayerl C, Van der Zee R, Morrison SG, Morrison RP, Xu Q, Wick G. Cross-reactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis. Arterioscler. Thrombo. Vasc. Biol. 2003; 23:1060-1065.
    16. Morrison RP. New insights into a persistent problem - chalamydial infections. J Clin Invest. 2003; 111:1647-1649.
    17. Kinnunen A, Surcel H-M, Halttunen M, Tiitinen A, Morrison RP, Morrison SG, Koskela P, Lehtinen M, Paavonen J. Chlamydia trachomatis heat shock protein- 60 induced inteferon-y and interleukin-10 production in infertile women. Clin.Exp.Immunol. 2003; 131:299-303.
    18. Bulut Y, Faure E, Thomas L, Karahashi H, Michelsen KS, Equils O, Morrison SG, Morrison RP, Arditi M. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor-4 and MD2 in a MyD88-dependent pathway. J Immunol. 2002; 168:1435-1440.
    19. Morrison RP, Caldwell HD. Mini Review. Immunity to murine chlamydial genital infection. Infect Immun. 2002; 70:2741-2751.
    20. Morrison SG, Su H, Caldwell HD, Morrison RP. Immunity to murine Chlamydia trachomatis genital tract infection involves B cells and CD4+ T cells but not CD8+ T cells. Infect Immun. 2000; 68:6979-6987.
    21. Morrison RP, RANK RG. CHLAMYDIAL SEQUELAE:MECHANISMS OF IMMUNE DAMAGE IN TRACHOMA AND GENITAL TRACT INFECTIONS. EFFECTS OF MICROBES ON THE IMMUNE SYSTEM. 2000; PP 41-55.
    22. Morrison RP. Differential sensitivity of Chlamydia trachomatis strains to the inhibitory effects of gamma inteferon. Infect Immun. 2000; 68:6038-6040.
    23. Mosorin M, Surcel H-M, Laurila A, Lehtinen M, Karttunen R, Juvonen A, Paavonen J, Morrison RP, Saikku P, Juvonen T. Detection of Chlamydia pneumoniae reactive T lymphocytes in human atherosclerotic plaques of carotid artery. Arterioscler. Thrombo. Vasc. Biol. 2000; 20:1061-1067.
    24. Kinnunen A, Molander P, Laurila A, Rantala I, Morrison RP, Lehtinen M, Karttunen R, Paavonen J, Surcel H-M. Chlamydia trachomatis reactive T lymphocytes from upper genital tract tissue specimens. Hum. Reprod. 2000; 15:1484-1489.
    25. LaVerda D, Albanese LN, Ruther P, Morrison SG, Morrison RP, Ault KA, Byrne GI. Seroreactivity to Chlamydia trachomatis hsp10 correlates with disease severity in women. Infect Immun. 2000; 68:303-309.
    26. Kalayoglu M, Hoerneman B, LaVerda D, Morrison SG, Morrison RP, Byrne GI. Cellular oxidation of low density lipoprotein by Chlamydia pneumoniade. J Infect Dis. 1999; 180:780-790.
    27. Su H, Morrison RP, Messer R, Whitmire W, Hughes S, Caldwell HD. The effect of antibiotic intervention on the development of protective immunity against chlamydial genital infection. J Infect Dis. 1999; 180:1252-1258.
    28. Morrison RP. Persistent Chlamydia trachomatis infection: an in vitro phenomenon or an in vivo trigger of reactive arthritis. J. Rheumatol. 1998; 25:610-612.
    29. Su H, Feilzer K, Caldwell HD, Morrison RP. Chlamydia trachomatis genetial tract infection of antibody-deficient gene knockout mice. Infect Immun. 1997; 65:1993-1999.
    30. Morrison RP. Immune protection against chlamydia trachomatis in females. Infec.Dis.Obstet.Gynecol. 1996; 4:163-170.
    31. Rosenberg HF, Morrison RP, Li F. Identification of a 40-kDa human protein that crossreacts with prokaryotic HSP60/chaperonins. Biochem.Biophys. Res.Commun. 1995; 208:697-703.
    32. Arno JN, Yuan Y, Cleary RE, Morrison RP. Serologic response of infertile women to the 60-kd chlamydial heat shock protein (hsp60). Fertility Sterility. 1995; 64:730-735.
    33. Morrison RP, Feilzer K, Tumas DB. Gene knockout mice establish a primary protective role for MHC class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect Immun. 1995; 63:4661-4668.
    34. Beatty WL, Morrison RP, Byrne GI. Persistent Chlamydia: from cell culture to a paradigm for chlamydial pathogenesis. Microbiological Rev. 1994; 58:686-699.
    35. Beatty WL, Belanger TA, Desal AA, Morrison RP, Byrne GI. Role of tryptophan in gamma-inteferon mediated chlamydial persistence. 1994; 730:304-306.
    36. Beatty WL, Morrison RP, Byrne GI. Immuno electron-microscopic quantitation of different levels of chlamydial proteins ina cell culture model of persistent Chlamydia trachomatis infection. 1994; 62:4059-4062.
    37. Byrne GI, Stephens RS, Ada G, Caldwell HD, Su H, Morrison RP, Van der Pol B, et al. Workshop on the in vitro neutralization of Chlamydia trachomatis: Summary of proceedings. 1993; 168:415-420.
    38. Beatty WL, Byrne GI, Morrison RP. Morphologic and antigenic characterization of interferon-y mediated persistent Chlamydia trachomatis infection in vitro. 1993; 90:3998-4002.
    39. Morrison RP, MANNING DS, CALDWELL HD. IMMUNOLOGY OF CHLAMYDIA TRACHOMATIS INFECTIONS: IMMUNOPROTECTIVE AND IMMONOPATHOGENIC RESPONSES. ADVANCES IN HOST DEFENSE MECHANISMS VOL. 8. 1992; PP 57-84.
    40. Yuan Y, Lyng K, Zhang Y-X, Rockey DD, Morrison RP. Monoclonal antibodies define genus-specific, species-specific,and cross-reactive epitopes of the chlamydial 60 kilodalton heat shock protein (hsp60): specific immunodetection and purification of chalmydial hsp60. Infect Immun. 1992; 60:2288-2296.
    41. Morrison RP, Su H, Lyng K, Yuan Y. Chlamydia trachomatis hyp operon is homologous to the groE stress response operon of Escherichia coli. Infect Immun. 1990; 58:2701-2705.
    42. Su H, Morrison RP, Watkins NG, Caldwell HD. Identification and characterization of T hyper-cell epitopes of the major outer membrane protein of Chlamydia trachomatis. J Exp Med. 1990; 172:203-312.
    43. Morrison RP. CHLAMYDIAL 57-KILODALTON STRESS RESPONSE PROTEIN IS A DELETERIOUS IMMUNE TARGET. MICROBIAL DETERMINANTS OF VIRULENCE AND HOST RESPONSE. 1990; PP 243-250.
    44. Morrison RP. IMMUNE RESPONSES TO CHLAMYDIA ARE PROTECTIVE IN PATHOGENETIC. INTERNATIONAL SYMPOSIUM ON HUMAN CHALAMYDIAL INFECTIONS. 1990; PP 163-172.
    45. Morrison RP, Belland RJ, Lyng K, Caldwell HD. Chaamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein. J Exp Med. 1989; 170:1271-1283.
    46. Morrison RP, CHESEBRO B, NISHIO J, WEHRLY K, EARL P, MOSS B. INDUCTION OF PRIMED T LYMPHOCYTES AND PROTECTION AGAINST FRIEND MURINE LEUKEMIA BY RECOMBINANT VACCINIA VIRUS EXPRESSING THE FRIEND RETROVIRUS ENVELOPE GENE. VACCINES 87: MODERN APPROACHES TO NEW VACCINES. 1987; PP 268-272.
    47. Morrison RP, Nishio J, Chesebro B. Influence of the murine major histocompatibility complex (H-2) on Friend leukemia virus-induced immunosuppression. J Exp Med. 1986; (163:301-314).
    48. Morrison RP, NISHIO J, CHESEBRO B. IMMUNOSUPPRSSION INDUCED BY THE FRIEND MURINE LEUKEMIA VIRUS COMPLEX IN MICE WITH RFV-3r/s GENOTYPE. ANIMAL MODELS OF RETROVIRUS INFECTION AND THEIR RELATIONSHIP TO AIDS. 1986; PP 279-284.
    49. Beatty WL, Belinger TA, Desal AA, Morrison RP, Byrne GI. Tryptophan depletion as a mechanism of gamma inteferon-mediated chlamydial persistence. 62:3705-3711.
    50. Morrison RP, Lyng K, Caldwell HD. Chlamydial disease pathogenesis. Ocular hypersensitivity elicited by a genus-specific 57-kD protein. 169:663-675.
    51. Morrison RP. Chlamydia hsp60 and the immunopathogenesis of chalmydial diseases. 3:25-33.
    52. Morrison RP, Cutler JE. In vitro studies of the interactions of murine phagocytic cells in Candida albicans. (29:23-34).
    53. Beatty WL, Belinger TA, Le KD, Desai AA, Morrison RP, Byrne GI. Chlamydial persistence: mechanism of induction and parallels to a stress related response. 415-418.
    54. Kinnunen A, Surcel H-M, Lehtinen M, Karhukorpi J, Tiitinen A, Halttunen M, Bloigu A, Kivela H, Morrison RP, Karttunen R, Paavonen J. HLA DQ alleles and interleukin-10 polymorphism associated with Chlamydia trachomatis-related tubal factor infertility: a case control study. Hum. Reprod. 17:2073-2078.
    55. Evans LH, Morrison RP, Malik FG, Portis J, Britt WJ. A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic and amphotropic murine leukemia viruses.
    56. Beatty WL, Byrne GI, Morrison RP. Repeated and persistent infection with Chalmydia and the development chronic inflammation and disease. (2:94-98).
    57. Morrison RP, Earl PL, Nishio J, Lodnell DL, Moss B, Chesebro B. Different H-2 subregions influence immunization against retrovirus and immunosuppression. 329:729-732.
    58. Earl PL, Moss B, Morrison RP, Wehrly K, Nishio J, Chesebro B. T lymphocyte primimg and protestion against Friend leukemia by a vaccinia-retrovirus env gene recombinant.
    Morrison's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description